Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Supporters often emphasize the potential for meaningful therapeutic benefits, particularly in ailments where conventional medications have proven inadequate. However, crucially important to evaluate the substantial financial burden associated with CPI ste